Ropes & Gray has advised Alnylam Pharmaceuticals on the transaction, and Davis Polk has advised the initial purchasers and the counterparties to the capped call transactions.Alnylam…
Alnylam Pharmaceuticals Completes $661.25 Million Convertible Senior Notes Offering

























